SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 29, 2003
OR
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 0-16453
HearUSA, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 22-2748248 | |
|
|
||
| (State of Other Jurisdiction of | (I.R.S. Employer | |
| Incorporation or Organization) | Identification No.) | |
| 1250 Northpoint Parkway, West Palm Beach, Florida | 33407 | |
|
|
||
| (Address of Principal Executive Offices) | (Zip Code) | |
Registrants Telephone Number, Including Area Code (561) 478-8770
Former Name, Former Address and Former Fiscal Year,
if Changed Since Last Report
Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days Yes ü No
Indicate by check whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes No ü
On April 25, 2003, 30,423,616 shares of the Registrants Common Stock were outstanding, including 3,406,460 exchangeable shares of HEARx Canada, Inc.
INDEX
| Page | |||||||||
PART
I |
FINANCIAL INFORMATION | ||||||||
Item 1 |
Financial Statements: | ||||||||
| Consolidated Balance Sheets | |||||||||
| March 29, 2003 and December 28, 2002 | 3 | ||||||||
| Consolidated Statements of Operations | |||||||||
| Three months ended March 29, 2003 and March 30, 2002 | 4 | ||||||||
| Consolidated Statements of Cash Flows | |||||||||
| Three months ended March 29, 2003 and March 30, 2002 | 5 | ||||||||
| Notes to Consolidated Financial Statements | 6-11 | ||||||||
Item 2 |
Management's Discussion and Analysis of Financial Condition | ||||||||
| and Results of Operations | 12-17 | ||||||||
Item 3 |
Quantitative and Qualitative Disclosures About Market Risk | 18 | |||||||
Item 4: |
Controls and Procedures | 18 | |||||||
PART II |
OTHER INFORMATION | ||||||||
Item 6 |
Exhibits and Reports on Form 8-K | 19-21 | |||||||
| Signatures | 22 | ||||||||
| Certifications Pursuant to Section 302 of the | |||||||||
| Sarbanes - Oxley Act of 2002 | 23-24 | ||||||||
| Exhibit Index | 25 | ||||||||
2
Part I Financial Information
Item 1. Financial Statements
HearUSA, Inc.
Consolidated Balance Sheets
ASSETS
| March 29, | December 28, | |||||||||||||||||
| 2003 | 2002 | |||||||||||||||||
| (unaudited) | ||||||||||||||||||
Current assets: |
||||||||||||||||||
Cash and cash equivalents |
$ | 6,947,333 | $ | 2,527,671 | ||||||||||||||
Investment securities |
553,034 | 550,046 | ||||||||||||||||
Accounts and notes receivable, less allowance for
doubtful accounts of $1,261,277 and $1,342,897 |
8,177,921 | 7,145,692 | ||||||||||||||||
Inventories |
1,077,751 | 980,120 | ||||||||||||||||
Prepaid expenses and other
|
1,047,209 | 912,959 | ||||||||||||||||
Total current assets |
17,803,248 | 12,116,488 | ||||||||||||||||
Property and equipment net |
6,931,805 | 7,240,249 | ||||||||||||||||
Intangibles, net (Note 4) |
45,023,500 | 45,026,088 | ||||||||||||||||
Deposits and other |
483,037 | 482,982 | ||||||||||||||||
| $ | 70,241,590 | $ | 64,865,807 | |||||||||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||||||||||
Current liabilities: |
||||||||||||||||||
Accounts payable |
$ | 13,512,965 | $ | 10,938,056 | ||||||||||||||
Accrued expenses |
4,140,884 | 3,738,857 | ||||||||||||||||
Accrued salaries and other compensation |
1,633,783 | 2,382,495 | ||||||||||||||||
Current maturities of long term debt |
3,969,514 | 4,073,285 | ||||||||||||||||
Dividends payable |
1,128,541 | 1,215,167 | ||||||||||||||||
Total current liabilities |
24,385,687 | 22,347,860 | ||||||||||||||||
Long term debt, less current maturities |
25,004,075 | 22,082,389 | ||||||||||||||||
Commitments and contingencies (Note 6) |
| | ||||||||||||||||
Stockholders equity: |
||||||||||||||||||
Preferred stock: |
||||||||||||||||||
(Aggregate liquidation preference $8,021,541 and $8,108,167) $1
par, 5,000,000 shares authorized |
||||||||||||||||||
Series J (233 & 233 shares outstanding) |
233 | 233 | ||||||||||||||||
Series H Junior Participating (0 shares outstanding) |
| | ||||||||||||||||
1998 Convertible (4,563 shares outstanding)
|
4,563 | 4,563 | ||||||||||||||||
Total preferred stock |
4,796 | 4,796 | ||||||||||||||||
Common stock: $.10 par; 50,000,000 -
shares authorized; |
||||||||||||||||||
27,490,485 and 24,457,055 shares issued |
2,749,048 | 2,445,705 | ||||||||||||||||
Stock subscription |
(412,500 | ) | (412,500 | ) | ||||||||||||||
Additional paid-in capital |
117,011,338 | 117,314,681 | ||||||||||||||||
Accumulated deficit |
(96,564,218 | ) | (96,765,446 | ) | ||||||||||||||
Accumulated Other comprehensive income currency
translation adjustment (Note 1) |
548,505 | 331,763 | ||||||||||||||||
Treasury stock, at cost:523,662 & 518,660 common shares |
(2,485,141 | ) | (2,483,441 | ) | ||||||||||||||
Total stockholders equity |
20,851,828 | 20,435,558 | ||||||||||||||||
| $ | 70,241,590 | $ | 64,865,807 | |||||||||||||||
See accompanying notes to the consolidated financial statements
3
HearUSA, Inc.
Consolidated Statements of Operations
Three Months Ended March 29, 2003 and March 30, 2002
| March 29 | March 30, | |||||||||
| 2003 | 2002 | |||||||||
| (unaudited) | (unaudited) | |||||||||
Net Revenues |
$ | 18,580,271 | $ | 12,010,016 | ||||||
Operating costs and expenses: |
||||||||||
Cost of products sold |
5,559,602 | 3,405,098 | ||||||||
Center operating expenses |
8,616,499 | 6,759,936 | ||||||||
General and administrative expenses |
2,568,963 | 2,386,551 | ||||||||
Depreciation and amortization |
963,036 | 523,598 | ||||||||
Total operating costs and expenses |
17,708,100 | 13,075,183 | ||||||||
Income (loss) from operations |
872,171 | (1,065,167 | ) | |||||||
Non-operating income (expense): |
||||||||||
Interest income |
4,218 | 22,066 | ||||||||
Interest expense |
(526,837 | ) | (280,230 | ) | ||||||
Income (loss) before equity in loss of affiliated
company |
349,552 | (1,323,331 | ) | |||||||
Equity in loss of affiliated company |
| (61,405 | ) | |||||||
Net income (loss) |
349,552 | (1,384,736 | ) | |||||||
Dividends on preferred stock |
(148,324 | ) | (168,069 | ) | ||||||
Net income (loss) applicable to common
stockholders |
$ | 201,228 | $ | (1,552,805 | ) | |||||
Net income (loss) per common share basic |
$ | 0.01 | $ | (0.11 | ) | |||||
Net income (loss) per common share diluted |
$ | 0.01 | $ | (0.11 | ) | |||||
Weighted average number of shares of
Common stock outstanding: |
||||||||||
Basic |
30,426,106 | 14,057,243 | ||||||||
Diluted |
55,836,097 | 14,057,243 | ||||||||
See accompanying notes to the consolidated financial statements
4
HearUSA, Inc.
Consolidated Statements of Cash Flows
Three Months Ended March 29, 2003 and March 30, 2002
| March 29, 2003 | March 30, 2002 | ||||||||||
| (unaudited) | (unaudited) | ||||||||||
Cash flows from operating activities: |
|||||||||||
Net income(loss) |
$ | 349,552 | $ | (1,384,736 | ) | ||||||
Adjustments to reconcile net income (loss) to net cash provided by operating
activities: |
|||||||||||
Depreciation and amortization |
963,036 | 523,598 | |||||||||
Provision for doubtful accounts |
67,550 | 39,750 | |||||||||
Loss on disposition of equipment |
| 911 | |||||||||
Equity loss in affiliated company |
| 61,405 | |||||||||
Compensation expense from the issuance
of capital stock |
| 40,250 | |||||||||
Changes in assets and liabilities: |
|||||||||||
(Increase) decrease in: |
|||||||||||
Accounts and notes receivable |
(1,099,779 | ) | 1,267,318 | ||||||||
Inventories |
(97,631 | ) | 65,889 | ||||||||
Prepaid expenses and other |
(115,739 | ) | 91,344 | ||||||||
Increase (decrease) in: |
|||||||||||
Accounts payable and accrued expenses |
2,976,936 | (92,181 | ) | ||||||||
Accrued salaries and other |
(748,712 | ) | (215,796 | ) | |||||||
Net cash provided by operating activities |
2,295,213 | 397,752 | |||||||||
Cash flow from investing activities: |
|||||||||||
Purchase of property and equipment |
(113,958 | ) | (199,240 | ) | |||||||
Purchase of pre-combination investment in Helix |
| (2,000,000 | ) | ||||||||
Cost of business combination |
| (97,937 | ) | ||||||||
Net cash used in investing activities |
(113,958 | ) | (2,297,177 | ) | |||||||
Cash flows from financing activities: |
|||||||||||
Proceeds from issuance of: |
|||||||||||
Long-term debt |
3,500,000 | | |||||||||
Principal payments: Long-term debt |
(1,077,288 | ) | (1,036,174 | ) | |||||||
Purchase of treasury stock |
(1,700 | ) | | ||||||||
Exchange & redemption of capital stock |
| (301,093 | ) | ||||||||
Proceeds from issuance of capital stock,
net of offering costs |
| 1,500,000 | |||||||||
Dividends on preferred stock |
(234,950 | ) | (45,047 | ) | |||||||
Net cash provided by financing activities |
2,186,062 | 117,686 | |||||||||
Effects of exchange rate changes on cash |
52,345 | | |||||||||
Net increase (decrease) in cash and cash
equivalents |
4,419,662 | (1,781,739 | ) | ||||||||
Cash and cash equivalents at beginning of period |
2,527,671 | 5,561,608 | |||||||||
Cash and cash equivalents at end of period |
$ | 6,947,333 | $ | 3,779,869 | |||||||
Supplemental disclosure of non-cash investing and financing activities: |
|||||||||||
Purchase of investment in affiliated company by
exchanging notes receivable from affiliated
company |
$ | | $ | 2,700,000 | |||||||
See accompanying notes to the consolidated financial statements
5
HearUSA, Inc.
Notes to Consolidated Financial Statements
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation have been included. Operating results for the three month period ended March 29, 2003 are not necessarily indicative of the results that may be expected for the year ending December 27, 2003. For further information, refer to the audited consolidated financial statements and footnotes thereto included in the Companys annual report on Form 10-K for the year ended December 28, 2002.
1. Summary of Significant Accounting Policies
Helix Transaction
On July 27, 2001, the Company and Helix Hearing Care of America Corp., a Canadian corporation (Helix), signed a definitive merger agreement, which was subsequently amended and restated as of November 6, 2001. Helix owned or managed, prior to the combination, 126 hearing healthcare clinics located in Massachusetts, New York, Ohio, Michigan, Wisconsin, Minnesota, Washington and Missouri as well as in the Provinces of Ontario and Quebec. The transaction was approved by the stockholders of both HEARx and Helix on June 26, 2002 and by the Canadian courts on June 28, 2002. The transaction closed on July 11, 2002, and is effective June 30, 2002,the first day of the Companys third quarter of 2002, for financial reporting purposes. In connection with the completion of the business combination, on July 8, 2002 the Company changed its name from HEARx Ltd. to HearUSA, Inc. and increased its authorized capital. The Companys common stock continues to trade on the American Stock Exchange under the symbol EAR.
As of March 29, 2003, 3,456,793 exchangeable shares of HEARx Canada, Inc., an indirect subsidiary of the Company, were issued or will be issued to certain former common shareholders of Helix in connection with the combination. Each exchangeable share of HEARx Canada, Inc. is exchangeable for one share of the Companys common stock. The exchangeable shares are traded on the Toronto Stock Exchange under the symbol HUX.
Earnings Per Share
For purposes of computing net income per common share basic and diluted, for the three months ended March 29, 2003, the weighted average number of shares of common stock outstanding includes the effect of the 3,456,793 exchangeable shares of HEARx Canada, Inc. described above, as if they were outstanding common stock of the Company on June 30, 2002, the effective date of the combination for financial reporting purposes. For computing net income earnings per share diluted for the three months ended March 29, 2003, 25,409,991 shares were included for convertible preferred stock.
Basis of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly owned and majority controlled subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.
6
HearUSA, Inc.
Notes to Consolidated Financial Statements
Investment in Affiliated Company
Prior to the closing of the combination with Helix, the Company owned approximately 10.5 percent of the common stock of Helix. The Company accounted for this investment using the equity method because the Company had the ability to exercise significant influence over the operational and financial policies of Helix as a result of the terms of the merger agreement with Helix and the use of certain proceeds of the Companys credit facility with Siemens Hearing Instruments, Inc. (Siemens) to repay certain debts of Helix. Under the equity method, the Company recorded its proportionate share of profits and losses of the affiliated company based on its percentage interest in the affiliated company.
Comprehensive Income
Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. The Companys other comprehensive income represents a foreign currency translation adjustment.
Comprehensive income (loss) and the components of other comprehensive income are as follows:
| March 29, | March 30, | |||||||
| 2003 | 2002 | |||||||
Comprehensive income (loss): |
||||||||
Net income (loss) for period |
$ | 349,552 | $ | (1,384,736 | ) | |||
Other comprehensive income: |
||||||||
Foreign currency translation adjustments |
216,742 | 15,085 | ||||||
Comprehensive income (loss) for the period |
$ | 566,294 | $ | (1,369,651 | ) | |||
Reclassifications
Certain amounts in the 2002 consolidated financial statements have been reclassified in order to conform to the 2003 presentation.
Segments
Since the closing of the Helix transaction, the Company operates in three business segments, which include the operation and management of centers, the establishment, maintenance and support of an affiliated network and the operation of an e-commerce business . The Companys business units are located in the United States and Canada.
| Centers | E-commerce | Network | Corporate | Total | |||||||||||||||||
Net Revenues |
|||||||||||||||||||||
3 months ended 3/29/03 |
$ | 18,292,000 | $ | 19,000 | $ | 269,000 | $ | | $ | 18,580,000 | |||||||||||
3 months ended 3/30/02 |
12,010,000 | | | | 12,010,000 | ||||||||||||||||
Income (Loss) from
Operations |
|||||||||||||||||||||
3 months ended 3/29/03 |
3,922,000 | (14,000 | ) | 130,000 | (3,166,000 | ) | 872,000 | ||||||||||||||
3 months ended 3/30/02 |
1,498,000 | | | (2,563,000 | ) | (1,065,000 | ) | ||||||||||||||
3 months ended 3/29/03
Depreciation and
amortization |
482,000 | | 1,000 | 480,000 | 963,000 | ||||||||||||||||
Identifiable assets |
45,650,000 | | 1,857,000 | 22,735,000 | 70,242,000 | ||||||||||||||||
Capital Expenditures |
103,000 | | | 11,000 | 114,000 | ||||||||||||||||
3 months ended 3/30/02
Depreciation and
amortization |
347,000 | | | 177,000 | 524,000 | ||||||||||||||||
Identifiable assets |
6,011,000 | | | 13,811,000 | 19,822,000 | ||||||||||||||||
Capital Expenditures |
159,000 | | | 40,000 | 199,000 | ||||||||||||||||
7
HearUSA, Inc.
Notes to Consolidated Financial Statements
Income (Loss) from Operations at the segment level are computed before general and administrative expenses.
Stock-based compensation
The Company has granted stock options to employees and directors under stock option plans. The Company accounts for those plans using the intrinsic value method under Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. Stock-based employee compensation cost reflected in net income (loss) is not significant, as all options granted under those plans had an exercise price greater than or equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net income (loss) and income (loss) per share if the Company had applied the fair value recognition provisions of SFAS No. 123, (SFAS 123) Accounting for Stock-Based Compensation, to stock-based employee compensation:
| March 29, | March 30, | ||||||||
| 2003 | 2002 | ||||||||
Net income (loss) applicable to Common Stockholders |
$ | 201,228 | $ | (1,552,805 | ) | ||||
As reported |
|||||||||
Deduct: Total stock-based employee
compensation expense determined under
fair value based method for all awards |
(45,000 | ) | (98,000 | ) | |||||
Pro forma |
$ | 156,228 | $ | (1,650,805 | ) | ||||
Income (loss) per share basic and diluted |
|||||||||
As reported |
$ | 0.01 | $ | (0.11 | ) | ||||